ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

BMC Cancer

Volumn 9, Issue , 2009, Pages 357-

  Videira, Paula A ^a   Correia, Manuela ^a   Malagolini, Nadia ^b   Crespo, Hélio J ^a   Ligeiro, Dário ^c   Calais, Fernando M ^d   Trindade, Helder ^a,c   Dall'Olio, Fabio ^b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Ministerio da Saude Portuguese   (Portugal)

^d HOSPITAL DE SÃO JOSÉ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; SIALYLTRANSFERASE; ST3 BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE 1; ST3GAL.2 SIALYLTRANSFERASE; ST3GAL.4 SIALYLTRANSFERASE; T ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; DOT HYBRIDIZATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SIALYLATION; UROTHELIUM;

EID: 70449515088     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-357     Document Type: Article

References (36)

1. Lamm DL, McGee WR, Hale K. Bladder cancer: current optimal intravesical treatment. Urol Nurs 2005, 25:323-332.
2. Huben RP. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer. Semin Urol Oncol 1996, 14(1 Suppl 1):17-22.
3. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie 2001, 83:727-737. 10.1016/S0300-9084(01)01301-3, 11530204.
4. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 2002, 99:10231-10233. 10.1073/pnas.172380699, 124893, 12149519.
5. Dimitroff CJ, Pera P, Dall'Olio F, Matta KL, Chandrasekaran EV, Lau JT, Bernacki RJ. Cell surface N-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 1999, 256:631-636. 10.1006/bbrc.1999.0388, 10080950.
6. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005, 5:526-542. 10.1038/nrc1649, 16069816.
7. Holmberg LA, Oparin DV, Gooley T, Sandmaier BM. The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope). Clin Breast Cancer 2003, 3(Suppl 4):S144-51. 10.3816/CBC.2003.s.004, 12620152.
8. Chefalo P, Pan Y, Nagy N, Guo Z, Harding CV. Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine. Biochemistry 2006, 45:3733-3739. 10.1021/bi052161r, 2531244, 16533056.
9. O'Boyle KP, Coatsworth S, Anthony G, Ramirez M, Greenwald E, Kaleya R, Steinberg JJ, Dutcher JP, Wiernik PH. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn. Cancer Immun 2006, 6:5.
10. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999, 1473:67-95.
11. Dall'Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconj J 2001, 18:841-850. 10.1023/A:1022288022969, 12820717.
12. Burchell J, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D, Taylor-Papadimitriou J. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 1999, 9:1307-1311. 10.1093/glycob/9.12.1307, 10561455.
13. Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, Lai CR, Hsieh SL, Yuan CC. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol 2005, 99:631-639. 10.1016/j.ygyno.2005.07.016, 16112178.
14. Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, Nishihara S, Narimatsu H. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 1998, 78:797-811.
15. Schneider F, Kemmner W, Haensch W, Franke G, Gretschel S, Karsten U, Schlag PM. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1, 3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 2001, 61:4605-4611.
16. Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ, Zhang CO, Koch KR, Michejda CJ. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 2004, 101:11803-11808. 10.1073/pnas.0404509101, 511055, 15282374.
17. Langkilde NC, Wolf H, Clausen H, Kjeldsen T, Orntoft TF. Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression. Cancer 1992, 69:219-227. 10.1002/1097-0142(19920101)69:1<219::AID-CNCR2820690136>3.0.CO;2-A, 1727666.
18. Yokoyama M, Ohoka H, Oda H, Oda T, Utsumi S, Takeuchi M. Thomsen-Friedenreich antigen in bladder cancer tissues detected by monoclonal antibody. Hinyokika Kiyo 1988, 34:255-258.
19. Yamada T, Fukui I, Yokokawa M, Oshima H. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression. Cancer 1988, 61:721-726. 10.1002/1097-0142(19880215)61:4<721::AID-CNCR2820610415>3.0.CO;2-5, 3338034.
20. Przybylo M, Hoja-Lukowicz D, Litynska A, Laidler P. Different glycosylation of cadherins from human bladder non-malignant and cancer cell lines. Cancer Cell Int 2002, 2:6. 10.1186/1475-2867-2-6, 140134, 12234377.
21. Kajiwara H, Yasuda M, Kumaki N, Shibayama T, Osamura Y. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder. Tokai J Exp Clin Med 2005, 30:177-182.
22. Videira PA, Calais FM, Correia M, Ligeiro D, Crespo HJ, Calais F, Trindade H. Efficacy of Bacille Calmette-Guerin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines. Urology 2009, 74(4):944-50. 10.1016/j.urology.2009.02.053, 19428084.
23. Videira PA, Ligeiro D, Correia M, Trindade H. Gene expression analysis in superficial bladder cancer: comparison of two suitable endogenous reference genes. Curr Urol 2007, 1:145-150.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
25. Dall'Olio F, Malagolini N, Guerrini S, Lau JT, Serafini-Cessi F. Differentiation-dependent expression of human beta-galactoside alpha 2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells. Glycoconj J 1996, 13:115-121. 10.1007/BF01049687, 8785482.
26. Videira PA, Amado IF, Crespo HJ, Alguero MC, Dall'Olio F, Cabral MG, Trindade H. Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J 2008, 25:259-268. 10.1007/s10719-007-9092-6, 18080182.
27. Heney NM, Daly J, Prout GR, Nieh PT, Heaney JA, Trebeck NE. Biopsy of apparently normal urothelium in patients with bladder carcinoma. J Urol 1978, 120:559-560.
28. Pereira ME, Kabat EA, Lotan R, Sharon N. Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin. Carbohydr Res 1976, 51:107-118. 10.1016/S0008-6215(00)84040-9, 1033785.
29. Kitagawa H, Paulson JC. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem 1994, 269:17872-17878.
30. Hsu CC, Lin TW, Chang WW, Wu CY, Lo WH, Wang PH, Tsai YC. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecol Oncol 2005, 96:415-422. 10.1016/j.ygyno.2004.10.010, 15661230.
31. Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, Lance P. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 2001, 1536:148-160.
32. Amado M, Yan Q, Comelli EM, Collins BE, Paulson JC. Peanut agglutinin high phenotype of activated CD8+ T cells results from de novo synthesis of CD45 glycans. J Biol Chem 2004, 279:36689-36697. 10.1074/jbc.M405629200, 15210702.
33. Shio Y, Suzuki H, Kawaguchi T, Ohsugi J, Higuchi M, Fujiu K, Kanno R, Ohishi A, Gotoh M. Carbohydrate status detecting by PNA is changeable through cancer prognosis from primary to metastatic nodal site: A possible prognostic factor in patient with node-positive lung adenocarcinoma. Lung Cancer 2007, 57:187-192. 10.1016/j.lungcan.2007.02.007, 17383051.
34. Langkilde NC, Orntoft TF. A comparative study of peanut agglutinin and amaranthin binding to human urinary bladder tumor glycoproteins. Scand J Urol Nephrol Suppl 1995, 172:57-64.
35. Nakanishi K, Kawai T, Suzuki M. Lectin binding and expression of blood group-related antigens in carcinoma-in-situ and invasive carcinoma of urinary bladder. Histopathology 1993, 23:153-158. 10.1111/j.1365-2559.1993.tb00473.x, 8406387.
36. Malagolini N, Santini D, Chiricolo M, Dall'Olio F. Biosynthesis and expression of the Sda and sialyl Lewis × antigens in normal and cancer colon. Glycobiology 2007, 17:688-697. 10.1093/glycob/cwm040, 17395692.